|
|
|
|
| Advertisement |
 |
|
|
| Pricing |
 |
|
The WHO Fair Pricing Forum |
Ed Schoonveld reviews the key topics discussed at the World Health Organization's second Fair Pricing Forum, held in Johannesburg, South Africa last month
… /Read more/ |
|
|
| Advertisement |
 |
Deloitte's 2019 Life Sciences accounting and financial reporting update
Insights on new accounting standards and more
A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment.
 Download the full report here
|
|
|
ADVERTISEMENT
|
|
| Advertisement |
 |
|
|
| Pricing: UK |
 |
|
A (New) Tale of Two Pricing Schemes |
The UK has had in place what amount to two pricing schemes for branded medicines for years. But with major changes to both schemes set out in 2018, it’s now a new tale of two pricing schemes. Leela Barham reports
… /Read more/ |
|
|
|
| Technology |
 |
|
The AI Patient Arc: Past, Present, Future |
The story of how AI is improving all aspects of life science is still being written. But AI’s future impact on patients’ daily health will be informed and influenced by the work being realized today, writes Opinder Bawa
… /Read more/ |
| |
|
|
| Advertisement |
Register for Tuesday’s free live webcast “Sustainable Sourcing and Supply Chain Engagement in Pharma.” Various aspects of the pharma sourcing process and supplier relationships offer opportunities to advance sustainability and strategic goals. These include alternative raw materials at manufacturing facilities (e.g., biomass and recycled plastic), sourcing of renewable materials (e.g., palm oil), partnering on supplier sustainability, and more. This May 7 event is sponsored by BASF, Sustainable Brands, and Pharmaceutical Technology.
 Register now
|
|
| Regulatory |
| Advertisement |
Patient Adherence: A Hard Pill to Swallow?
On Demand
 Learn More
|
|
|
| Audio |
|
|
|
ADVERTISEMENT
 |
| Industry update |
| //Yu-Waye (Wayne) Chu, M.D., joined Fate Therapeutics (San Diego, CA) as Vice President, Clinical Development.
//
Aduro Biotech (Berkeley, CA), appointed Dimitry S.A. Nuyten, M.D., Ph.D., as Chief Medical Officer.
//
Elaine V. Jones, Ph.D., joined the Board of Directors of CytomX Therapeutics (South San Francisco, CA).
//
Jennifer M. Kissner, Ph.D., joined Outlook Therapeutics (Cranbury, NJ) as Senior Vice President, Clinical Development.
|
|
|
|
|
|
|
|
|
